sera
At 1 or 2 months after simultaneous       administration of the 3 above-mentioned DMARDs was begun, significant       improvements were seen in markers of joint inflammation, i.e., erythrocyte       sedimentation rate and C-reactive protein in sera.
At 1 or 2 months after simultaneous       administration of the 3 above-mentioned DMARDs was begun, significant       improvements were seen in markers of joint inflammation, i.e., erythrocyte       sedimentation rate and  @OBJECT$   @PREDICAT$   @SUBJECT$ .